Local corticosteroid injection versus physical therapy for the treatment of carpal tunnel syndrome: A systematic review and meta-analysis of randomized controlled trials. Left-sided major ...

Southwest Research Institute (SwRI) has developed new technology to enhance clinical bone imaging and decrease osteoporotic fractures in the elderly. The tool, described in a new SwRI-led study ...

Feb. 11, 2025 — Researchers have discovered a new mechanism that is used by a male sex hormone essential for muscle and bone function. The findings could lead to the development of new drugs ...

Astellas has suffered another major setback with geographic atrophy (GA) treatment Izervay, this time in the US. The company has received a complete response letter (CRL) from the FDA for a ...

Regeneron Pharmaceuticals has announced results from the phase 3 QUASAR trial and its extension study of the phase 3 PULSAR trial investigating EYLEA HD (aflibercept) Injection 8 mg. The QUASAR trial ...

BMC Musculoskelet Disord. 2010;11(136) © 2010 BioMed Central, Ltd.

EYLEA’s unique MoA: What is the rationale for the higher molar dose?